10.21147/j.issn.1000-9604.2020.03.02
Immune checkpoint inhibitors for treatment of advanced gastric or gastroesophageal junction cancer: Current evidence and future perspectives
32
This work was supported by the National Key Research and Development Program of China No.2017YFC 1308900
2020-08-28(万方平台首次上网日期,不代表论文的发表时间)
共16页
287-302